Title of the Project
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
Service Line not in Drupal
Surgery
Affiliated Specialties not in Drupal
Name of Publication
Breast Cancer Research and Treatment